Skip to search formSkip to main contentSkip to account menu

Wnt-5a Mimic Hexapeptide Foxy-5

Known as: Foxy-5 
A formylated, six amino acid, Wnt5a-derived peptide and wnt-5a mimetic with potential anti-metastatic activity. Upon intravenous administration, Wnt… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Involvement of WNT signaling pathway in the adult hippocampal synapses :role in neuroprotection.
Tesis (Doctor en Ciencias Biologicas, mencion en Biologia Celular y Molecular)--Pontificia Universidad Catolica de Chile, 2014. 
2014
2014
WntResearch has now received a US Patent for its Lead Cancer Compound Foxy-5
WntResearch AB (WNT.ST) announces that the United States Patent and Trademark Office has issued the company’s patent on Foxy-5 as… 
2013
2013
WntResearch: Release of Foxy-5 GMP material for planned clinical trial
WntResearch AB (WNT.ST) announces successful manufacturing of its lead product Foxy-5. WntResearch has finalized the… 
2010
2010
43 Estrogen receptor alpha is upregulated and metastasis inhibited in a murine breast cancer model following treatment with the novel Wnt-5a derived-hexapeptide, Foxy-5
2008
2008
TheWnt-5 a ^ Derived Hexapeptide Foxy-5 Inhibits Breast Cancer Metastasis In vivo byTargeting Cell Motility
Purpose: An inherent problem in breast cancer treatment is that current therapeutic approaches fail to specifically target the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)